News & Updates
Showing Psychiatry articles
Showing
Show Multimedia Only

Zuranolone for sleeplessness promising in early study
19 Jan 2022
The orally bioavailable, investigational neuroactive steroid zuranolone appears to be beneficial in the treatment of insomnia, producing improvements in sleep measures, including sleep efficiency, duration of awakenings, and total sleep time in adults, according to the results of a phase I study.
19 Jan 2022

Depression, antiseizure medication side effects take toll on epileptic patients’ quality of life
17 Jan 2022
byJairia Dela Cruz
Among patients with epilepsy, quality of life (QOL) declines with antiseizure medication (ASM) polytherapy, and this effect is mediated by depression and the side effects of ASMs, as reported in a study.
17 Jan 2022

Psychosis not uncommon in Parkinson’s disease, signals cognitive decline
14 Jan 2022
byStephen Padilla
A significant presence of psychosis exists among patients with Parkinson’s disease (PD) in Singapore, potentially indicating a more rapid cognitive decline and progression of PD severity, reports a study.
14 Jan 2022





